The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

31 Jan 2018 11:04

RNS Number : 4841D
FastForward Innovations Limited
31 January 2018
 

31 January 2018

 

 

FastForward Innovations Ltd

("FastForward" or the "Company")

Transaction in Own Shares

FastForward Innovations Limited (AIM: FFWD) (the "Company") announces that it has made the following redemptions pursuant to the extension to the share buyback programme (the "Buyback Programme") announced on 19 January 2018:

Date of purchase:

22 January

Number of Ordinary Shares purchased:

670,000

Highest price paid per Ordinary Share:

£0.1780

Lowest price paid per Ordinary Share:

£0.1751

Volume weighted average price per Ordinary Share:

£0.1762

 

Date of purchase:

23 January

Number of Ordinary Shares purchased:

175,000

Highest price paid per Ordinary Share:

£0.1797

Lowest price paid per Ordinary Share:

£0.1775

Volume weighted average price per Ordinary Share:

£0.1791

 

 

Following the repurchase of the shares set out above, the Company's issued share capital consists of 136,144,498 Ordinary Shares. 4,793,623 Ordinary shares are held in Treasury. For reporting under the FCA's Disclosure and Transparency Rules, Shareholders should exclude any shares held in Treasury and should use the figure of 131,350,875 Ordinary Shares (the issued voting share capital) when determining if they are required to notify their interest, or a change of their interest in the Company

The Company will make further announcements in due course following the completion of any further purchases pursuant to the Buyback Programme.

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 details of the purchase of its own ordinary shares by the Company, which were all executed through the Company's broker, Optiva Securities Limited, are set out below:

Schedule of Purchases:

Shares purchased:

FastForward Innovations Limited (ISIN: GG00BRK9BQ81)

Dates of purchase:

22 January 2018

 

23 January 2018

 

 

Aggregate Information:

 

Aggregated volume

Volume weighted average price

Venue

845,000

£0.1768

AIM market, London Stock Exchange PLC

 

 

 

Individual transactions

 

 

 

 

 

Date of purchase:

Time of purchase:

Number of Ordinary Shares purchased:

Price paid per Ordinary Share (p)

Volume weighted average price per Ordinary Share

 

22/01/2018

13:46

25,000

17.8

17.8

 

22/01/2018

13:40

100,000

17.7

17.7

 

22/01/2018

13:25

100,000

17.51

17.51

 

22/01/2018

13:12

75,000

17.57

17.57

 

22/01/2018

12:59

35,000

17.58

17.58

 

22/01/2018

12:17

60,000

17.595

17.595

 

22/01/2018

12:10

50,000

17.6

17.6

 

22/01/2018

10:23

50,000

17.675

17.675

 

22/01/2018

10:00

75,000

17.63

17.63

 

22/01/2018

10:06

100,000

17.675

17.675

 

 

 

 

 

 

 

23/01/2018

12:57

100000

17.97

17.97

 

23/01/2018

10:51

50000

17.9

17.9

 

23/01/2018

10:25

25000

17.75

17.75

 

 

 

 

 

FastForward Innovations Limited

info@fstfwd.co

Sue Saunders / Ian Burns

 

 

Beaumont Cornish Limited (Nomad) Tel: +44 (0) 207 628 3396

James Biddle / Roland Cornish

 

 

Optiva Securities Limited (Broker) Tel: +44 (0) 203 411 1881

Ed McDermott

 

          

CAUTIONARY STATEMENT

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of Fast Forward Innovations Ltd. There can be no assurance that such statements will prove to be accurate, achievable or recognizable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Fast Forward Innovations assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSLLFILLVILVIT
Date   Source Headline
25th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
18th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
11th Feb 20207:00 amRNSUpdated Key Information Document
31st Jan 20201:30 pmRNSInvestee Company Update: Portage Biotech Inc.
8th Jan 20207:00 amRNSDisposal of Interest in Cryptologic Corp
7th Jan 20207:00 amRNSBoard Appointment
3rd Jan 20201:15 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Dec 20197:00 amRNSHalf-year Report
5th Dec 20192:45 pmRNSTR-1 Notification
19th Nov 20197:00 amRNSLorne Abony appointed as Chairman of EMMAC
16th Oct 20197:00 amRNSInvestee Company Update: EMMAC Life Sciences
15th Oct 20197:00 amRNSInvestee Company Update: Factom inc.
10th Oct 20199:25 amRNSResult of 2019 AGM
27th Sep 20194:31 pmRNSDirector Dealing in the Company
27th Sep 20197:00 amRNSInvestee Company Update : Fralis LLC (Leap Gaming)
26th Sep 201911:21 amRNSInvestee Company Update : Cryptologic Corp
16th Sep 201911:52 amRNSTR-1 Notification of major holdings
11th Sep 20198:00 amRNSResults for the year ended 31st March 2019
11th Sep 20198:00 amRNSNotice of 2019 Annual General Meeting
22nd Aug 201912:01 pmRNSDirectorate Change
19th Aug 20199:23 amRNSJuvenescence closes Series B funding
12th Aug 20193:02 pmRNSInvestee Company Update-Cryptologic issues loan
12th Aug 201910:11 amRNSPortage Trading Suspended
6th Aug 20194:42 pmRNSInvestee Company Update: Cryptologic Corp
30th Jul 201911:07 amRNSSAFE Agreement with Factom, Inc. Extended
25th Jul 20198:17 amRNSFactom Inc SAFE Agreement temporary extension
18th Jul 201911:20 amRNSInvestee Company Update: Regent Pacific on Yooya
16th Jul 20199:13 amRNSInvestee Company Update:EMMAC acquires Terre Verde
11th Jul 20193:00 pmRNSDisposal of interest in Intensity Therapeutics Inc
9th Jul 201910:51 amRNSInvestee Company Update: EMMAC enters new Market
26th Jun 20198:56 amRNSInvestee Company Update: Intensity Therapeutics
29th May 20193:43 pmRNSInvestee Company Update: Offer for Yooya
13th May 201910:21 amRNSDisposal of interest in Vemo Education Inc.
18th Apr 20197:00 amRNSInvestee Company Update: Intensity Therapeutics
4th Apr 20199:51 amRNSTR1 - Correction
3rd Apr 20194:00 pmRNSTR:1 Regent Mercantile Holdings Limited
20th Mar 201911:00 amRNSCompletion of £2 million investment in EMMAC
7th Mar 20194:03 pmRNS£2 million investment in EMMAC Life Sciences
15th Jan 20193:45 pmRNSJuvenescence Series B Funding
3rd Jan 201911:47 amRNSBoard Appointment
12th Dec 201812:52 pmRNSHalf-year Report
3rd Dec 20187:00 amRNSInvestee Company Update: Factom and Yooya
14th Nov 20181:31 pmRNSInvestee Company Update: Factom Inc
22nd Oct 201812:24 pmRNSIntensity Therapeutics Inc Update
12th Sep 20186:12 pmRNSResult of AGM
10th Sep 20189:16 amRNSHolding(s) in Company
22nd Aug 20188:08 amRNSDirector Dealing
3rd Aug 201812:48 pmRNSShareholder update
3rd Aug 20188:00 amRNSPlacing
1st Aug 201812:05 pmRNSResponse to Media Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.